Emerging Therapeutics in the Treatment of Substance Use Disorders: A Focus on GLP-1 Receptor Agonists, D3R Antagonists, and CRF Antagonists
The prevalence and rising use of alcohol, opioids, and stimulants have led to substance use disorders (SUDs) that are a significant public health challenge. Traditional treatments offer some benefit; however, they often limited by efficacy, side effects, and accessibility, highlighting the urgent ne...
Saved in:
| Main Authors: | Khaled Draghmeh, Brian Fuehrlein |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2025-04-01
|
| Series: | Journal of Integrative Neuroscience |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/JIN/24/4/10.31083/JIN26361 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CRF1 receptor antagonists in congenital adrenal hyperplasia: A systematic review and meta-analysis of phase 2 open-label and phase 3 clinical trials
by: Mir wajid Majeed, et al.
Published: (2025-06-01) -
The role of cannabinoid agonists and antagonists on folliculogenesis and evolutionary events in the mouse ovary
by: Vida Mirzaie, et al.
Published: (2025-09-01) -
A new era for the design of TRPV1 antagonists and agonists with the use of structural information and molecular docking of capsaicin-like compounds
by: Julio Caballero
Published: (2022-12-01) -
Pain Intensity in Patients with Opioid Use Disorder on Extended-Release Naltrexone or Opioid Agonists; The Role of COMT rs4680 and OPRM1 rs1799971: An Exploratory Study
by: Juya F, et al.
Published: (2025-02-01) -
Efficacy of a melatonin receptor agonist and orexin receptor antagonists in preventing delirium symptoms in the olderly patients with stroke: a retrospective study
by: Yukiko Miyoshi, et al.
Published: (2024-11-01)